Literature DB >> 29703333

Optimising initial treatment for peripheral T-cell lymphoma: a tough nut to CHOP.

Ryan A Wilcox1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29703333     DOI： 10.1016/S2352-3026(18)30047-4

Source DB:  PubMed          Journal:  Lancet Haematol        ISSN： 2352-3026            Impact factor:   18.959


× No keyword cloud information.
  4 in total

1.  Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma-not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry.

Authors:  Shigeo Fuji; Shuhei Kida; Kayo Nakata; Toshitaka Morishima; Isao Miyashiro; Jun Ishikawa
Journal:  Ann Hematol       Date:  2020-10-21       Impact factor: 3.673

Review 2.  Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas.

Authors:  Alexander Neuwelt; Taha Al-Juhaishi; Eduardo Davila; Bradley Haverkos
Journal:  Blood Adv       Date:  2020-09-08

3.  Increasing Evidence for the Association of Breast Implant-Associated Anaplastic Large Cell Lymphoma and Li Fraumeni Syndrome.

Authors:  Julian Adlard; Cathy Burton; Philip Turton
Journal:  Case Rep Genet       Date:  2019-07-16

4.  AGENT ORANGE-INDUCED Anaplastic Large-Cell Lymphoma (ALCL) with Cutaneous Involvement.

Authors:  Morgan Lorio; Brandon Lewis; John Hoy; Matthew Yeager
Journal:  Clin Case Rep       Date:  2021-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.